WeVote
Log In

Bill

Bill

SF 315

A bill for an act relating to pharmacy benefits manager reverse auctions and group insurance for public employees and including effective date provisions.

2025-2026 Regular Session

Iowa law requires pharmacy benefits managers to use competitive reverse auctions for public employee health plan drugs, increasing pricing transparency and potentially lowering drug costs.

Rereferred to Commerce.
#administrativeservicesdepartment #auctions #contracts #dependentpersons #drugs #groupinsurance #insurance #pharmacybenefitsmanagers #prices #publicemployees #vendors
0
WeVote Research Nonpartisan
Bill Summary · SF 315

Legislative bill overview

SF 315 establishes requirements for pharmacy benefits managers (PBMs) to conduct reverse auctions when providing pharmacy benefits to Iowa public employee group insurance plans. The bill aims to increase transparency and competition in drug pricing by requiring PBMs to solicit competitive bids from pharmacies rather than unilaterally setting reimbursement rates.

Why is this important

PBMs control drug pricing and reimbursement between insurers and pharmacies, creating a largely opaque market where public employees and their employers have limited visibility into actual drug costs. This bill directly affects healthcare costs for Iowa's public workforce and taxpayer-funded insurance programs, potentially reducing pharmaceutical expenses through competitive bidding.

Potential points of contention

  • PBM business model disruption: Reverse auctions may reduce PBM profit margins and could prompt industry pushback or challenges to implementation feasibility
  • Pharmacy network impact: Smaller independent pharmacies may struggle to compete in auctions, potentially consolidating market share toward larger chains
  • Administrative burden: Public employers must oversee new auction processes, requiring additional compliance infrastructure and staff training
  • Drug access concerns: Aggressive price competition could reduce pharmacy participation, affecting rural or underserved areas with limited pharmacy options

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.